10/17/2025
3:15 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/14/2025
3:30 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2025
3:30 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2025
3:30 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2025
4:00 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2025
10:53 AM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2025
3:32 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2025
12:50 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2025
4:31 PM | Vir Biotechnology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/04/2025
11:27 AM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2025
5:46 PM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VIR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter. |
07/17/2025
3:18 PM | Eisner Mark (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2025
7:11 PM | Eisner Mark (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
4:59 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
4:04 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025
5:39 PM | MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:55 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
7:26 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:22 PM | MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:26 PM | Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:27 PM | Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:28 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:31 PM | Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:17 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:19 PM | Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:20 PM | Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
3:29 PM | Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2025
7:23 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
12:02 PM | BlackRock, Inc. (Filed by)
Vir Biotechnology (Subject)
| Form SCHEDULE 13G/A | |
04/17/2025
8:27 AM | Vir Biotechnology (Filer)
| Form ARS | |
04/17/2025
7:40 AM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/17/2025
7:33 AM | Vir Biotechnology (Filer)
| Form DEF 14A | |
04/04/2025
3:23 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
6:50 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
11:39 AM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:01 AM | Vir Biotechnology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
3:23 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
2:43 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:44 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:34 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:36 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/25/2025
2:37 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:39 PM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:41 PM | O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:56 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:57 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:57 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:38 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:40 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
6:11 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:50 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
5:41 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:49 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
6:51 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:03 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:22 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
6:50 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
12:36 PM | O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:20 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:51 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
3:20 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:26 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
